Document Type


Publication Date


Source Publication

Clinical and Investigative Medicine. Volume 27, Number 1 (2004), p. 23-32.


advertisements; Canada; DTC advertising; DTC campaign by Myriad; genetic testing; health law; private access; regulatory system


This article has 4 intents: 1. to highlight the major players and targeted consumers in the realm of private access to genetic testing and DTC advertising. 2. to canvass arguments for and against private access to commercially available genetic testing. 3. to analyze the recent DTC campaign by Myriad as an example of what may be on the horizon for Canada. 4. to question the adequacy of Canada's current regulatory system to deal with advertisements of this nature and, by examining the routes taken in other jurisdictions, to explore the potential for an improved regulatory framework specific to genetic testing services.

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.